Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine
- PMID: 10900277
- DOI: 10.1056/NEJM200007203430304
Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine
Abstract
Background: Radiographic contrast agents can cause a reduction in renal function that may be due to reactive oxygen species. Whether the reduction can be prevented by the administration of antioxidants is unknown.
Methods: We prospectively studied 83 patients with chronic renal insufficiency (mean [+/-SD] serum creatinine concentration, 2.4+/-1.3 mg per deciliter [216+/-116 micromol per liter]) who were undergoing computed tomography with a nonionic, low-osmolality contrast agent. Patients were randomly assigned either to receive the antioxidant acetylcysteine (600 mg orally twice daily) and 0.45 percent saline intravenously, before and after administration of the contrast agent, or to receive placebo and saline.
Results: Ten of the 83 patients (12 percent) had an increase of at least 0.5 mg per deciliter (44 micromol per liter) in the serum creatinine concentration 48 hours after administration of the contrast agent: 1 of the 41 patients in the acetylcysteine group (2 percent) and 9 of the 42 patients in the control group (21 percent; P=0.01; relative risk, 0.1; 95 percent confidence interval, 0.02 to 0.9). In the acetylcysteine group, the mean serum creatinine concentration decreased significantly (P<0.001), from 2.5+/-1.3 to 2.1+/-1.3 mg per deciliter (220+/-118 to 186+/-112 micromol per liter) 48 hours after the administration of the contrast medium, whereas in the control group, the mean serum creatinine concentration increased nonsignificantly (P=0.18), from 2.4+/-1.3 to 2.6+/-1.5 mg per deciliter (212+/-114 to 226+/-133 micromol per liter) (P<0.001 for the comparison between groups).
Conclusions: Prophylactic oral administration of the antioxidant acetylcysteine, along with hydration, prevents the reduction in renal function induced by contrast agents in patients with chronic renal insufficiency.
Comment in
-
Acetylcysteine and nephrotoxic effects of radiographic contrast agents--a new use for an old drug.N Engl J Med. 2000 Jul 20;343(3):210-2. doi: 10.1056/NEJM200007203430311. N Engl J Med. 2000. PMID: 10900284 No abstract available.
-
N-acetylcysteine and contrast-induced nephropathy.N Engl J Med. 2006 Oct 5;355(14):1499; author reply 1499-500. N Engl J Med. 2006. PMID: 17024738 No abstract available.
Similar articles
-
The prevention of radiocontrast-agent-induced nephropathy by hemofiltration.N Engl J Med. 2003 Oct 2;349(14):1333-40. doi: 10.1056/NEJMoa023204. N Engl J Med. 2003. PMID: 14523141 Clinical Trial.
-
Reno-protective effect of N-acetyl cysteine in patients with impaired renal function undergoing coronary angiography and interventions.J Assoc Physicians India. 2006 Jun;54:449-52. J Assoc Physicians India. 2006. PMID: 16909692
-
Oral acetylcysteine as an adjunct to saline hydration for the prevention of contrast-induced nephropathy following coronary angiography. A randomized controlled trial and review of the current literature.Eur Heart J. 2004 Feb;25(3):212-8. doi: 10.1016/j.ehj.2003.11.011. Eur Heart J. 2004. PMID: 14972421 Review.
-
Ascorbic acid prevents contrast-mediated nephropathy in patients with renal dysfunction undergoing coronary angiography or intervention.Circulation. 2004 Nov 2;110(18):2837-42. doi: 10.1161/01.CIR.0000146396.19081.73. Epub 2004 Oct 18. Circulation. 2004. PMID: 15492300 Clinical Trial.
-
New pharmacological protocols to prevent or reduce contrast media nephropathy.Minerva Cardioangiol. 2005 Feb;53(1):49-58. Minerva Cardioangiol. 2005. PMID: 15788979 Review.
Cited by
-
Guidelines on the use of iodinated contrast media in patients with kidney disease 2012: digest version : JSN, JRS, and JCS Joint Working Group.Clin Exp Nephrol. 2013 Aug;17(4):441-79. doi: 10.1007/s10157-013-0843-3. Clin Exp Nephrol. 2013. PMID: 23896863 No abstract available.
-
N-acetylcysteine does not prevent post-endoscopic retrograde cholangiopancreatography hyperamylasemia and acute pancreatitis.World J Gastroenterol. 2006 Jun 21;12(23):3751-5. doi: 10.3748/wjg.v12.i23.3751. World J Gastroenterol. 2006. PMID: 16773694 Free PMC article. Clinical Trial.
-
[Acute renal failure and sepsis : Just an organ dysfunction due to septic multiorgan failure?].Anaesthesist. 2010 Aug;59(8):682-99. doi: 10.1007/s00101-010-1767-x. Anaesthesist. 2010. PMID: 20694713 Review. German.
-
Clinical factors associated with dense and wedge-shaped nephrograms detected 24 h after chemoembolization.Cardiovasc Intervent Radiol. 2009 Nov;32(6):1193-1201. doi: 10.1007/s00270-009-9692-6. Cardiovasc Intervent Radiol. 2009. PMID: 19911454 Free PMC article.
-
DNA origami nanostructures can exhibit preferential renal uptake and alleviate acute kidney injury.Nat Biomed Eng. 2018 Nov;2(11):865-877. doi: 10.1038/s41551-018-0317-8. Epub 2018 Nov 8. Nat Biomed Eng. 2018. PMID: 30505626 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical